epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Alli
    orlistat
  • remove Hydra-Zide
    hydralazine/ hydrochlorothiazide
  • remove Oxtellar XR
    oxcarbazepine

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Hydra-Zide (hydralazine/ hydrochlorothiazide) + Oxtellar XR (oxcarbazepine)

Monitor/Modify Tx


hydrochlorothiazide + oxcarbazepine

monitor sodium: combo may incr. risk of hyponatremia, seizures (additive effects)

Additional Considerations

Smiley face Smiley face orlistat in Alli

caution advised with concurrent oral narrow therapeutic index drugs with concerns for loss of efficacy; orlistat may decr. absorption of some oral drugs

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information